Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nitric oxide and atherosclerosis: an update.

Claudio Napoli1, Filomena de Nigris, Sharon Williams-Ignarro

  • 1Department of General Pathology and Excellence Research Center on Cardiovascular Diseases, First School of Medicine, II University of Naples, Naples 80134, Italy. claunap@tin.it

Nitric Oxide : Biology and Chemistry
|May 11, 2006
PubMed
Summary

Nitric oxide (NO) plays a key role in vascular health by promoting vasodilation and preventing platelet aggregation. Understanding NO's role and factors like L-arginine and eNOS gene variations is vital for cardiovascular disease management.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Postsurgery fluids promote transition of cancer stem cell toendothelial and AKT/mTOR activity contributing to relapse of giant cell tumors of bone.

Oncotarget·2026
Same author

Gliosarcoma: A Reappraisal of Neuroradiological, Surgical, Morphological, and Radiotherapeutic Characteristics of a Cohort From South Italy Single-Center.

Analytical cellular pathology (Amsterdam)·2026
Same author

Mitochondrial Dysfunction in Acute Kidney Injury: Intersections Between Chemotherapy and Novel Cancer Immunotherapies.

Biomolecules·2026
Same author

Correction: Mosca et al. Sarcoma Common MHC-I Haplotype Restricts Tumor-Specific CD8+ T Cell Response. <i>Cancers</i> 2022, <i>14</i>, 3414.

Cancers·2026
Same author

Targeting Metabolic and pH Regulatory Pathways in Cancer via Dual Inhibition of Nicotinamide Phosphoribosyltransferase and Carbonic Anhydrases IX and XII.

Journal of medicinal chemistry·2026
Same author

Epigenetic crosstalk between uric acid and vascular health: a role for extracellular vesicles.

Clinical epigenetics·2025

Area of Science:

  • Cardiovascular Science
  • Molecular Biology
  • Biochemistry

Background:

  • Nitric oxide (NO) is a critical regulator of vascular function, influencing vasorelaxation, endothelial repair, and inflammatory processes.
  • Atherosclerosis impairs nitric oxide (NO) bioavailability through reduced endothelial NO synthase (eNOS) activity and increased oxidative stress.
  • Many vasculoprotective therapies leverage NO production for their therapeutic effects.

Purpose of the Study:

  • To review the multifaceted role of nitric oxide (NO) in vascular disease.
  • To explore the impact of endothelial dysfunction and oxidative stress on NO bioavailability.
  • To discuss the therapeutic potential of NO precursors and the significance of eNOS gene polymorphisms in cardiovascular risk.

Main Methods:

Related Experiment Videos

  • Literature review of studies on nitric oxide (NO) and vascular disease.
  • Analysis of the mechanisms underlying NO modulation in atherosclerosis.
  • Examination of the role of L-arginine and eNOS gene variations.
  • Main Results:

    • Nitric oxide (NO) mediates key protective vascular functions including vasodilation and anti-platelet adhesion.
    • Endothelial dysfunction in atherosclerosis reduces NO bioavailability via decreased eNOS activity and enhanced NO degradation.
    • L-arginine supplementation shows promise in atherosclerosis, and eNOS gene polymorphism may serve as a cardiovascular risk predictor.

    Conclusions:

    • Nitric oxide (NO) is integral to vascular homeostasis and its dysfunction is central to vascular disease pathogenesis.
    • Targeting NO pathways, including L-arginine supplementation, represents a potential therapeutic strategy.
    • Further research is necessary to elucidate the clinical implications of eNOS gene polymorphisms for cardiovascular event prediction.